HOOK — Hookipa Pharma Balance Sheet
0.000.00%
- $10.71m
- -$29.56m
- $43.95m
- 26
- 64
- 23
- 29
Annual balance sheet for Hookipa Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 143 | 65.9 | 112 | 117 | 39.7 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 20.7 | 21.2 | 22 | 19.3 | 23.7 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 172 | 102 | 147 | 147 | 80.7 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 14 | 22.1 | 22 | 13.2 | 1.06 |
| Other Long Term Assets | |||||
| Total Assets | 188 | 126 | 170 | 161 | 82.5 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 21.1 | 27.7 | 35.6 | 42 | 24.7 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 31.7 | 36.5 | 67.9 | 71.5 | 31.3 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 156 | 89.6 | 103 | 89.9 | 51.2 |
| Total Liabilities & Shareholders' Equity | 188 | 126 | 170 | 161 | 82.5 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |